Statistics
Total Visits
| Views | |
|---|---|
| CYR61 und S100A4 als Targets für die Therapie des triple-negativen Mammakarzinoms sowie des Tamoxifen-resistenten Mammakarzinoms | 470 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| CYR61 und S100A4 als Targets für die Therapie des triple-negativen Mammakarzinoms sowie des Tamoxifen-resistenten Mammakarzinoms | 29 | 13 | 7 | 9 | 13 | 18 | 2 |
File Visits
| Views | |
|---|---|
| Hüchel_Silke_Dissertation_20.04.2022 .pdf | 207 |
Top country views
| Views | |
|---|---|
| United States | 150 |
| Germany | 140 |
| China | 39 |
| Sweden | 23 |
| Japan | 21 |
| Singapore | 17 |
| Brazil | 9 |
| France | 9 |
| Hong Kong | 6 |
| Russia | 6 |
Top cities views
| Views | |
|---|---|
| Frankfurt am Main | 25 |
| Ashburn | 19 |
| Göttingen | 18 |
| San Mateo | 17 |
| Singapore | 16 |
| Beijing | 9 |
| Placentia | 8 |
| Buffalo | 7 |
| Bonn | 6 |
| Bremen | 6 |